ℹ️
🇬🇧
Search
Search for publications relevant for "subkutánní aplikace"
subkutánní aplikace
Publication
Class
Person
Publication
Programmes
Export current view
publication
Praktické zkušenosti se subkutánní aplikací imunoglobulinů
2016 |
Second Faculty of Medicine
publication
Patient with follicular lymphoma and subcutaneous administration of rituximab
2014 |
Faculty of Medicine in Hradec Králové
publication
Subcutaneous administration of rituximab in B-non-Hodgkin's lymphoma patients
2014 |
Publication without faculty affiliation
publication
Studies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration
2009 |
First Faculty of Medicine
publication
Kinetic profiles of incorporation of some psychedelics into brain tissue after subcutaneous application to rats
2008 |
First Faculty of Medicine
publication
Subcutaneously delivered natalizumab for the treatment of highly active relapsing-remitting multiple sclerosis
2022 |
Faculty of Medicine in Hradec Králové
publication
Pharmacokinetics of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration
Publication without faculty affiliation
publication
Effect of hyaluronidase and PEG chain conjugation on the biologic and antitumor activity of RNa
2004 |
Faculty of Science
publication
|Application of insulin
Publication without faculty affiliation
publication
Ofatumumab - a highly effective therapy for relapsing-remitting multiple sclerosis available in the first line
2022 |
Faculty of Medicine in Hradec Králové
publication
The fastest insulin in the world
2018 |
Faculty of Medicine in Hradec Králové
publication
Ofatumumab and siponimod in the treatment of multiple sclerosis - case reports
2022 |
Faculty of Medicine in Hradec Králové
publication
Exenatide QW
2012 |
Second Faculty of Medicine
publication
Dalaglutid: průlom v injekční léčbě pacientů s diabetem
2018 |
Publication without faculty affiliation
publication
Ofatumumab
2021 |
First Faculty of Medicine
publication
Effective substitution of CSII with glargine insulin in a patient with an unstable type 1 diabetes mellitus
2004 |
Second Faculty of Medicine
publication
Ofatumumab - new and different monoclonal anti-CD20 antibody in the treatment of multiple sclerosis
2021 |
Second Faculty of Medicine
publication
Immunotherapies for food allergy
2019 |
Faculty of Medicine in Pilsen
publication
Multiple sclerosis patient suitable for the treatment with ofatumumab
2022 |
Faculty of Medicine in Hradec Králové
publication
The clinical signs of experimental autoimmune uveitis
2016